PubRank

Lillian Werner

Author PubWeight™ 33.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011 11.07
2 CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood 2010 1.82
3 SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2011 1.77
4 Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. J Natl Cancer Inst 2013 1.63
5 Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia. Clin Cancer Res 2011 1.46
6 Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance. J Urol 2010 1.40
7 Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci U S A 2012 1.34
8 Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res 2012 1.33
9 Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. Clin Cancer Res 2009 1.29
10 Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. Cancer Prev Res (Phila) 2011 1.17
11 MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS One 2011 1.12
12 FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med 2014 0.95
13 Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma. Clin Cancer Res 2014 0.90
14 Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy. Cancer Epidemiol Biomarkers Prev 2010 0.84
15 Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article. J Neurosurg Spine 2010 0.84
16 Using blocks of linked single nucleotide polymorphisms as highly polymorphic genetic markers for parentage analysis. Mol Ecol Resour 2008 0.82
17 Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS One 2013 0.82
18 Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. Br J Haematol 2010 0.80
19 Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia. Leuk Res 2013 0.78
20 Secondary hormonal therapy in men with castration-resistant prostate cancer. Clin Genitourin Cancer 2011 0.77
21 A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Haematologica 2013 0.76
22 Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations. Am J Hematol 2010 0.76